2024 Severe COVID-19 in Vaccinated Adults With Hematologic Cancers in the Veterans Health Administration. Sonia T. Anand, Austin D. Vo, Jennifer La, Nhan V. Do, Nathanael R. Fillmore, Mary Brophy, Westyn Branch-Elliman, Paul A. Monach JAMA Network Open7(2), e240288 U.S. Veterans and VA Data Case-Control Study Electronic Health Records COVID-19 Severe COVID-19
2024 Risk of severe coronavirus disease 2019 despite vaccination in patients requiring treatment with immune-suppressive drugs: A nationwide cohort study of US Veterans. Sonia T. Anand, Austin D. Vo, Jennifer La, Mary Brophy, Nhan V. Do, Nathanael R. Fillmore, Westyn Branch-Elliman, Paul A. Monach Transplant Infectious Disease26(1), e14168 U.S. Veterans and VA Data Electronic Health Records COVID-19 Severe COVID-19 Vaccine Effectiveness
2024 Underuse of Antiviral Drugs to Prevent Progression to Severe COVID-19 - Veterans Health Administration, March-September 2022. Paul A. Monach, Sonia T. Anand, Nathanael R. Fillmore, Jennifer La, Westyn Branch-Elliman MMWR: Morbidity and Mortality Weekly Report73(3), 57-61 U.S. Veterans and VA Data COVID-19 Severe COVID-19 Antiviral Therapy Hematologic Malignancies
